Quibim is a company leading at the forefront of imaging biomarkers research in life sciences, pioneering the development of advanced algorithms that transform imaging data into actionable predictions in oncology, immunology, and neurology.
The company was founded with the ambition to leverage imaging as a catalyst for precision health, improving clinical outcomes for patients and redefining medical treatment and monitoring.